Dear John,

Join Health Affairs tomorrow, October 21 for a virtual event examining the timing of new drug launches in low-, middle-, and high-income markets from 1982 to 2024.

This event is exclusive to Health Affairs Insiders.

Employer-sponsored health insurance is the largest source of coverage in the US, covering approximately 154 million nonelderly people as of 2022.

In an ahead-of-print article released earlier this month, Gary Claxton and coauthors explore what are employer strategies for covering GLP-1 agonists, mental health, substance use, and other family benefits as premiums continue to increase.

Allison Hoffman on Simplifying Medicaid Long-Term Services & Supports

Health Affairs' Editor-in-Chief Alan Weil interviews Allison Hoffman of University of Pennsylvania about her recent paper that explores opportunities to simplify Medicaid home and community-based services in the age of rebalancing.

Medicare Advantage Star Ratings Continue to Fade but Market Marches On Into 2025

Health Affairs' Jeff Byers welcomes Senior Editor Michael Gerber back to the program to discuss Medicare open enrollment, the newly-announced 2025 Medicare Advantage and Part D Star Ratings, and how large insurance companies may be scaling back Medicare Advantage product offerings.

Health Policy on the 2024 Presidential Campaign Trail

Health Affairs' Jeff Byers welcomes Senior Editor Ellen Bayer to the program to take a closer look at the health care-related topics tied to the upcoming US presidential election. The two cover home care, reproductive health, drug pricing, and more throughout their conversation.

Election Day is on the horizon and Health Affairs has been collecting articles that we've published over the years to reflect on evidence and analysis on key issues that impact the health policy sector.

Our Election 2024 Collection features journal and Forefront articles, health policy briefs, podcasts, and theme issues on topics including drug costs, reproductive health, the Affordable Care Act, and more.

Purchase the collection to access all paywalled articles for the low price of $39.95.

Lawsuit Challenging Nevada’s Public Option Dismissed

Zachary Baron and Sheela Ranganathan

part of our Following The ACA series

The US Supreme Court And The Uncertain Future Of Preventive Care

Richard Hughes IV

Bolstering Social Connection Among Dual-Eligible Individuals

Thomas K.M. Cudjoe and Kelsey McNamara

part of our Medicare And Medicaid Integration series

Ethics And Health Systems Change: Introduction

M Gregg Bloche

Texas Challenges Federal Privacy Protections For Reproductive Health Care

Sheela Ranganathan

The Case For Multilingual Patient Engagement

Rachel K. Feldman and Rose L. Molina

How State Policy Makers Can Tackle Medical Debt: Lessons From North Carolina

Kody H. Kinsley

“Low- And Middle-Income Countries Experienced Delays Accessing New Essential Medicines”

In the October issue of Health Affairs, Olivier Wouters and Jouni Kuha analyzed the timing of new drug launches in seventy-five markets from 1982 to 2024.

Join Health Affairs tomorrow, October 21 for a virtual Journal Club event featuring Health Affairs Deputy Editor Jessica Bylander and author Olivier Wouters to discuss the paper and its implications.